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Purpose: To evaluate the outcome for scleral fixation of a foldable acrylic intraocular lens 
(IOL) in aphakic post-pars plana vitrectomy eyes for vitreoretinal disease.
Methods: The medical records of 15 patients were reviewed. We evaluated such factors as 
the underlying vitreoretinal disease, preoperative expected refraction and postoperative actual 
refraction, best corrected visual acuity (BCVA), corneal endothelial cell density, and intraop-
erative and postoperative complications.
Results: The most common cause of underlying vitreoretinal disease was retinal detachment, 
which was found in 8 cases. The mean refractive error was −0.10 diopters (D). The mean 
minimum angle of resolution (logMAR) values of BCVA were 0.27 preoperatively and 0.14 
postoperatively. The mean corneal endothelial cell density was 2400 cells/mm2 preoperatively 
and 2187 cells/mm2 postoperatively. No significant differences were observed in either the 
logMAR values of BCVA or the corneal endothelial cell density before and after surgery. 
No intraoperative complications occurred in any of the patients. Postoperative complications 
occurred in a total of 7 eyes, and the most severe complications comprised 4 cases of transient 
ocular hypertension.
Conclusion: The results for the scleral fixation of foldable acrylic IOLs were good in aphakic 
post-vitrectomy eyes.
Keywords: scleral fixation, intraocular lens, aphakic post-pars plana vitrectomy eyes, severe 
vitreoretinal disease
Introduction
Intraocular lenses (IOLs) are universally preferred over either aphakic spectacles or contact 
lenses as a method of visual rehabilitation in aphakic patients.1 However, depending on the 
condition of the posterior capsule and ciliary zonule, the insertion of an IOL on the capsule 
may simply cause such problems as IOL displacement into the vitreous cavity, decentration, 
or tilting.2 Therefore, scleral fixation of IOLs is required in some cases.   However, the 
scleral fixation of an IOL can also lead to many complications, such as a decrease in the 
corneal endothelial cell density,3,4 refractive error after surgery,5 IOL dislocation,3–6 vitre-
ous hemorrhage,3–6 infection through the suture,7 and retinal detachment.3–5
Although the scleral fixation of an IOL in aphakic eyes after a previous pars plana 
vitrectomy combined with lensectomy has become more common owing to the progress 
made in vitrectomy surgical techniques in recent years, only a few studies1,8–10 have 
so far been reported.
To fill this gap in knowledge, we retrospectively evaluated the secondary scleral 
fixation of a foldable acrylic IOL in aphakic eyes after previous pars plana vitrectomy 
combined with lensectomy for vitreoretinal disease.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Patients and methods
The medical records of 15 patients (15 eyes; 10 men, 
5 women) who underwent scleral fixation of a foldable acrylic 
IOL in aphakic postvitrectomy eyes were reviewed between 
September 2006 and November 2009. Only one experienced 
surgeon of the Dokkyo Medical University Koshigaya 
Hospital, Saitama, Japan, performed all surgery. All patients 
had been followed for a minimum of 6 months (mean 
follow-up month ± standard deviation, 13.3 ± 6.9 months). 
The mean age of the patients was 63.3 ± 6.7 years. All 
patients had clinically significant cataracts preoperatively. 
The secondary implantation of an IOL was planned when 
the vitreoretinal disease had subsided and remained stable 
for a minimum of 3 months (7.2 ± 4.1 months).
The axial length was measured using the IOL Master 
(Carl Zeiss Meditec Co Ltd), a noncontact optical coherent 
biometry device. The IOL power was calculated using the 
SRK/T (Sanders–Retzlaff–Kraff theoretical) formula. Post-
operative refraction was calculated as an awareness refraction 
that was converted to the spherical equivalent refraction, 
and the postoperative refraction, postoperative best cor-
rected visual acuity (BCVA), and corneal endothelial cell 
density were measured at 6 months or longer postoperatively 
(15.1 ± 5.5 months).
The underlying vitreoretinal disease, preoperative 
expected refraction and postoperative actual refraction, 
preoperative and postoperative BCVA, preoperative and 
postoperative corneal endothelial cell density, and rate 
of intraoperative and postoperative complications were 
examined. The decimal visual acuity data were converted into 
logarithms of the minimum angle of resolution (logMAR) 
values. Transient ocular hypertension was defined as a pres-
sure over 25 mmHg, and transient ocular hypotension was 
defined as that under 5 mmHg. “Transient” means a certain 
period of time ranging from a few days to 2 weeks at most.
surgical technique
The surgical technique was individualized because of the 
complicated nature of the eyes due to a history of previous 
surgery. An infusion cannula utilizing a 20-gauge vitrectomy 
system was used to prevent eyeball collapse during surgery. 
The infusion cannula was placed 3.5 mm from the limbus 
in the inferotemporal quadrant before scleral fixation to 
clear the retropupillary space and maintain the intraocular 
pressure (IOP) during surgery. In 2 patients who had been 
administered intraocular silicone oil, the scleral fixation of 
the IOL was performed after the pars plana removal of the 
silicone oil.
A 3.5 mm superior scleral tunnel incision was made in 
all patients. The anterior chamber was filled with sodium 
hyaluronate 1% or sodium hyaluronate 3.0%–chondroitin 
sulfate 4.0%. An ab externo method with a 27-gauge needle 
was used. After a conjunctival peritomy was performed, 2 par-
tial thickness limbus-based triangular scleral flaps were created 
opposite each other at the 8 o’clock and 2 o’clock positions. 
The intraocular part of the suture was pulled out through the 
scleral incision. The free ends of the sutures were tied to the 
2 haptics at the site corresponding to the maximum spread of 
each haptic of a foldable acrylic IOL (VA-65BB, Hoya Corp). 
The VA-65BB IOL has a 6.5 mm optic, an overall length of 
13.0 mm, and poly(methyl methacrylate) haptics with a micro-
scopic indentation 1.3 mm from the tip (Figure 1). The IOL 
was secured by slowly pulling the external sutures to introduce 
the haptics into the ciliary sulcus. The needle attached to the 
10-0 polypropylene suture was then passed through the partial 
thickness of the sclera, and the suture was then tied to itself. 
The loop of the knot was buried under the scleral flap.
Figure  1  The  foldable  acrlylic  intraocular  lens  has  distended  poly(methyl 
methacrylate) haptics, and each haptic has a microscopic indentation 1.3 mm from 
the tip.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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After irrigation/aspiration was done to remove any 
residual viscoelastic material, a balanced salt solution was 
injected from the corneal side port to control the IOP and 
observe the wound adaptation. In eyes with inadequate 
wound sealing, a single or continuous 10-0 nylon suture was 
placed at the site of the scleral tunnel incision.
statistical analysis
The paired t-test was used to compare the preoperative 
logMAR values at BCVA, and the corneal endothelial cell 
density with the postoperative values.
Results
Underlying vitreoretinal disease
The underlying vitreoretinal diseases were rhegmatogenous 
retinal detachment (n = 8 eyes; 53.3%); proliferative diabetic 
retinopathy (n = 3 eyes; 20.0%); IOL displacement into 
the vitreous cavity (n = 2; 13.3%); endophthalmitis after 
epiretinal membrane surgery (n = 1; 6.7%); and eye trauma 
with a vitreous hemorrhage (n = 1; 6.7%).
Preoperative expected refraction  
and postoperative actual refraction
Figure 2 shows a comparison of the preoperative expected 
refraction with the actual postoperative refraction. An 
average refractive error, calculated as the preoperative 
expected refraction from the postoperative refraction, was 
−0.10 ± 0.77 diopters (D) (range −1.04 to 1.62 D).
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Figure 2 Preoperative expected refraction and postoperative actual refraction. The 
vertical axis represents the postoperative actual refraction, and the horizontal axis 
represents the preoperative expected refraction.
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Figure 3 Preoperative and postoperative logMAR values of BCVA. The vertical axis 
represents the logMAR values, the horizontal axis indicates the preoperative and 
postoperative BCVA.
Abbreviations: BCVA, best corrected visual acuity; logMAr, mean minimum angle 
of resolution.
Preoperative and postoperative BCVA
The preoperative BCVAs ranged from 0.03 to 1.2, and the 
postoperative best corrected decimal visual acuities ranged 
from 0.09 to 1.2. Figure 3 shows the preoperative and 
postoperative BCVA in the logMAR value. The preopera-
tive BCVA was 0.27 ± 0.42 (range −0.079 to 1.522), and 
the postoperative BCVA was 0.14 ± 0.31 (range −0.079 to 
0.398). No significant difference was seen between the eyes 
before and after the surgery (P = 0.05; paired t-test).
Preoperative and postoperative corneal  
endothelial cell density
Figure 4 shows the preoperative and postoperative corneal 
endothelial cell density. The mean preoperative corneal 
endothelial cell density was 2400 ± 199 cells/mm2 (range 1164 
to 2653 cells/mm2), and the postoperative corneal endothe-
lial cell density was 2187 ± 238 cells/mm2 (range 1031 to 
2646 cells/mm2). No significant difference was seen between 
the eyes before and after surgery (P = 0.10; paired t-test).
intraoperative and postoperative complications
No intraoperative complications occurred. The postoperative 
complications were transient ocular hypertension (n = 4); 
transient ocular hypotension (n = 1); IOL dislocation 
(n = 1); and vitreous hemorrhage (n = 1). Because there was 
some overlap in these cases, we counted the total number 
of eyes. Although transient ocular hypertension, transient 
ocular hypotension, and vitreous hemorrhage resolved 
without treatment during the observation course, the 2 eyes 
with IOL dislocation required further surgery to repair the Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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after the surgery compared with that observed before the 
surgery in both groups. However, no significant differences 
were observed between the groups.3 The postoperative corneal 
endothelial cell density was measured at 6 months or more 
postoperatively, and no significant difference in the eyes of 
these patients was seen in comparison with the preoperative 
corneal endothelial density described in this study.
Shimomura et al reported that ocular hypertension 
occurred in 8 of 19 eyes after scleral fixation of the 
IOL, but none of the eyes required glaucoma surgery.11 
Krause et al reported that ocular hypertension occurred in 52 
of the 119 eyes in their study after scleral fixation of the IOL, 
and 11 of these eyes needed subsequent glaucoma surgery.4 
Fortunately, none of the eyes needed glaucoma surgery in this 
study. Pre-existing glaucoma tended to occur in association 
with the ocular hypertension, but pars plana infusion lowered 
the rate of ocular hypertension after surgery.4 Pars plana infu-
sion was used in all cases in this study. No ocular hyperten-
sion after surgery occurred in any of the patients. To reduce 
postoperative complications, such as retinal detachment in 
scleral fixation of the IOL, the use of pars plana vitrectomy 
without severe vitreoretinal disease has lately been growing 
in popularity.11 Because pars plana vitrectomy itself may 
pose additional risks, more study is needed to establish the 
efficacy of the pars plana vitrectomy modality without any 
evidence of severe vitreoretinal disease.
Ahn et al reported the underlying vitreoretinal diseases 
in 21 eyes of patients who underwent scleral fixation of an 
IOL in aphakic vitrectomized eyes to be proliferative diabetic 
retinopathy in 9 eyes; proliferative vitreoretinopathy in 5 eyes; 
traumatic retinal detachment in 3 eyes; intraocular foreign 
body in 2 eyes; and uveitic retinal detachment in 2 eyes.10 
Hotta and Hotta also reported the underlying vitreoretinal 
diseases, which included retinal detachment in 17 eyes; 
diabetic retinopathy in 7 eyes; and other causes in 6 eyes.9 
Ahn et al reported a higher rate of proliferative diabetic 
retinopathy10 in comparison with this study. On the other 
hand, the findings reported by Hotta and Hotta9 were similar 
to those described in this study with regard to the underlying 
vitreoretinal diseases.
The VA-65BB, which is a foldable IOL that can be 
inserted through a 3.0 mm incision, was used in this study. 
Fass and Herman reported that large incisions were prone to 
demonstrate either intraoperative or postoperative hypotony, 
an especially dangerous situation for eyes that were essen-
tially empty of any vitreous support.8 As P366UV and 
CZ70BD IOLs require large incisions, their frequency of 
use may decrease in the future. Fass and Herman described 
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Figure  4  Preoperative  and  postoperative  corneal  endothelial  cell  density.  The 
vertical axis represents the corneal endothelial cell density, while the horizontal axis 
indicates the preoperation and postoperation values.
dislocation. The one eye that had iris capture is still under 
close observation.
Discussion
The actual refractive errors reported in a previous study on the 
scleral fixation of IOLs in aphakic vitrectomized eyes were 
observed to shift approximately −0.8 (D) toward myopia in 
comparison with the findings observed after normal cataract 
surgery.9 These data are useful because used IOLs were 
previously limited to AQ-110NV and have been studied in 
many cases.9 Hotta and Hotta, in their investigation, limited 
the used IOLs to only one kind and focused on refractive 
errors.9 No controls were included in this study, thus leading 
to a slight shift toward myopia. However, as the refractive 
error was over ±1.50 (D) for only 2 eyes, we therefore con-
sidered these findings to be representative of good results.
In a previous study on the scleral fixation of the intraocular 
lenses in aphakic vitrectomized eyes reported by Ahn et al, 
which was similar to our present study, the postoperative 
BCVA significantly improved in comparison with the pre-
operative BCVA after 6 months.10 The postoperative BCVA 
was measured at 6 months or later postoperatively, and no 
significant difference was observed in the eyes of these 
patients in comparison with the preoperative BCVA described 
in this study.
Ohtani et al divided scleral fixation of IOL into 2 groups 
and compared the first group of being continuously performed 
after cataract surgery with the secondary group of being per-
formed a few days after surgery.3 The postoperative corneal 
endothelial cell density significantly decreased at 12 months Clinical Ophthalmology
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a surgical technique for aphakic postvitrectomy eyes in 
which a foldable acrylic IOL was used to facilitate 4-point 
fixation with no tilt and good centration through a 2.75 to 
3.0 mm incision.8
Scleral fixation of the IOL tends to prolong the duration 
of surgery, thus resulting in a longer illumination of the 
retina by the surgical microscope. This is a risk factor for 
light-induced retinopathy.12 As yellow IOL protects the 
retina against light exposure,13 the use of a yellow IOL, either 
with or without pars plana vitrectomy, will therefore likely 
increase in the future.
There are several studies in the literature similar to this 
report.1,10 However, one important advantage of our study in 
comparison with the others is the fact that only one experi-
enced surgeon performed all the surgery. Some differences 
tend to occur when different surgeons perform a large amount 
of surgery and thus result in reduced accuracy.
The removal of a cataract during a vitrectomy is per-
formed to improve the surgeon’s visualization. The lens 
capsule was removed completely during vitrectomy. It is pos-
sible to maintain the part of anterior capsule for subsequent 
foldable IOL implantation without sutures. However, the 
remaining anterior capsule has a risk of developing irido-
capsular synechias, which may complicate the secondary 
IOL implantation and also negatively affect the occurrence 
of postoperative refractive errors.
However, only a few studies of this kind1,8–10 have so 
far been reported, and the findings presented in this study 
are therefore considered to be useful. We conclude that 
scleral fixation of foldable acrylic IOLs in aphakic post-
vitrectomy eyes can be safely performed because no severe 
problems have been found with regard to refraction, corneal 
endothelial cell density, or intraoperative and postoperative 
complications.
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